In a groundbreaking development, researchers have used CRISPR gene-editing technology to eliminate HIV from infected immune cells in laboratory settings. This revolutionary approach could potentially lead to the first-ever cure for HIV, moving beyond current treatments that merely suppress the virus rather than eradicate it.

The University of Amsterdam team demonstrated that CRISPR’s precise “molecular scissors” can target and remove HIV DNA integrated into human cells. While still in early stages, this proof-of-concept represents a crucial first step toward developing a functional cure. Meanwhile, Excision BioTherapeutics has already progressed to human trials with their CRISPR-based therapy EBT-101, marking the first clinical test of this technology against HIV.